What is the role of the Pediatric Committee (PDCO) in neonatal disorders?
The Pediatric Committee (PDCO) is a key component of the EMA that focuses on pediatric medicines, including those for neonates. The PDCO is responsible for assessing the Pediatric Investigation Plans (PIPs) submitted by pharmaceutical companies. PIPs outline the strategy for developing medicines intended for children, including neonates, ensuring that they are appropriately tested and labeled for pediatric use.
